Filter
1220
Text search:
immunity
Featured
130
278
Language
Document type
569
216
199
60
58
50
32
15
7
7
3
2
2
Countries / Regions
65
57
28
28
27
23
20
18
17
16
16
15
14
14
13
12
12
11
11
11
11
11
11
11
11
10
10
10
9
9
8
8
8
8
8
8
7
7
7
7
6
6
6
5
5
5
5
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
410
170
71
56
27
17
15
1
Toolboxes
269
86
84
64
55
45
30
30
24
23
21
20
20
17
16
14
13
8
7
5
5
4
1
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva
...
Plos Current Outbreaks November 21, 2014
BMC Medicine 2014, 12:196
http://www.biomedcentral.com/1741-7015/12/196
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment of people infecte
...
Principles and Target Product Criteria. Roadmap January 12, 2015
Fourth Edition
This publication provides information for identifying, classifying, marking, labelling, packaging, documenting and refrigerating infectious substances for transportation and ensuring their safe delivery.
The document provides practical guidance to facilitate compliance with applicable international
...
Up-to-date Literature review current through: Jan 2015. | This topic last updated: Jan 29, 2015.
